US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Last trade$98.34
Day change-$1.21 (-1.22%)
Day range$97.13 – $100.70
Volume154,354
Market cap$1.49B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$1.49B
Price / earnings
—
Price / book
3.46×
Price / sales
1.77×
EV / sales
2.02×
EV / EBITDA
17.09×
Profitability
Earnings per share
-$1.35
Return on assets
-1.55%
Return on equity
-4.69%
Dividend yield
1.86%
Liquidity and leverage
Debt / equity
0.57×
Current ratio
1.42×
Quick ratio
1.42×
Cash ratio
0.35×
Cash flow
Price / cash flow
16.73×
Price / free cash flow
21.51×
Free cash flow
$69.1M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for USPH, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$222.56M
$214.06M
$198.29M
$202.73M
$197.13M
$197.34M
$183.79M
$180.45M
Cost of revenue
$179.53M
$0
$0
-$468.7M
$160.26M
$0
$0
-$399.5M
Gross profit
$43.03M
$214.06M
$198.29M
$671.43M
$36.87M
$197.34M
$183.79M
$579.95M
Selling, general and administrative
$17.83M
$144.41M
$137.76M
$480.02M
$17.41M
$131.26M
$127.49M
$414.97M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$17.93M
$192.11M
$185.81M
$654.66M
$11.54M
$172.41M
$164.15M
$560.3M
Operating income
$25.1M
$21.95M
$12.48M
$16.77M
$25.33M
$24.94M
$19.64M
$19.65M
Interest expense
-$3.58M
-$3.21M
$0
$0
-$2.41M
-$2.42M
$0
$0
Income before taxes
$21.56M
$19.05M
$10.56M
$14.96M
$22.88M
$22.65M
$17.33M
$18.32M
Income taxes
$3.97M
$4.16M
$2.41M
$5.78M
$5.23M
$4.93M
$3.86M
$5.83M
Net income
$17.59M
$14.9M
$8.16M
$9.18M
$17.64M
$17.72M
$13.47M
$12.49M
Net income attributable to common shareholders
-$15.54M
$3.81M
-$1.84M
-$6.55M
$7.24M
$8.82M
$12.06M
$7.9M
EBITDA
$31.35M
$27.88M
$18.48M
$21.4M
$31.16M
$31M
$25.51M
$27.75M
Basic earnings per share
-$1.04
$0.25
-$0.12
-$0.43
$0.48
$0.58
$0.80
$0.52
Diluted earnings per share
-$1.04
$0.25
-$0.12
-$0.43
$0.48
$0.58
$0.80
$0.52
Recent news
Company coverage with links to the original publishers.
U.S. Physical Therapy reported Q3 2026 earnings of $0.80 per share, beating consensus estimates of $0.76, with revenues of $222.56 million exceeding expectations by 3.56%. However, the company has only surpassed EPS estimates once in the last four quarters. Assigned a Zacks Rank #3 (Hold), the stock is expected to perform in line with the market. The company has underperformed the S&P 500 year-to-date with an 8.5% gain versus the index's 10.6%.
U.S. Physical Therapy, Inc. (USPH) presented at the BofA Securities 2026 Healthcare Conference on May 13, 2026. CEO Chris Reading discussed the company's operating environment, key initiatives, and growth opportunities. USPH operates 784 outpatient physical therapy clinics across 44 states and provides industrial injury prevention services.
U.S. Physical Therapy (USPH) reported record Q1 2026 revenue of $198.3 million, up 7.9% year-over-year, with adjusted EBITDA of $20.2 million. The company reaffirmed full-year 2026 guidance of $102-106 million adjusted EBITDA and secured an expanded $450 million credit facility. However, net income declined to $5.0 million from $9.9 million due to changes in contingent earn-out valuations and redeemable noncontrolling interests.
U.S. Physical Therapy, Inc. (USPH) announced it will report Q1 2026 financial results on May 6, 2026 after market close, with a conference call scheduled for May 7, 2026. The company operates 783 outpatient physical therapy clinics across 44 states and provides industrial injury prevention services.
U.S. Physical Therapy (USPH) closed a $450 million, five-year credit facility consisting of a $175 million term loan and $275 million revolver, maturing April 14, 2031. The facility was upsized from the initial $400 million launch and replaces the company's previous $325 million credit facility. The increased capacity, improved pricing, and extended maturity reflect strong lender confidence and will support growth and shareholder returns.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Nov 16, 2026
$0.46
Dec 11, 2026
recurring
Aug 21, 2026
$0.46
Sep 11, 2026
recurring
May 22, 2026
$0.46
Jun 12, 2026
recurring
Mar 13, 2026
$0.46
Apr 10, 2026
recurring
Nov 17, 2025
$0.45
Dec 12, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.